Impact of alloimmunity on chronic tissue remodelling: Role of cytokines and protective genes in the vessel wall

Transplant Immunology

Volumn 5, Issue 4, 1997, Pages 277-281

  Hancock, Wayne W ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2;

ALLOIMMUNITY; APOPTOSIS; BLOOD VESSEL WALL; GENE; HEART TRANSPLANTATION; IMMUNOGLOBULIN DEFICIENCY; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER;

EID: 0031454984     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(97)80008-1     Document Type: Article

References (35)

1. Billingham ME. Graft coronary disease: the lesions and the patients. Transplant Proc. 21:1989;3665-3666.
2. Sayegh MH, Perico N, Imberti O, et al. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation. 56:1993;461-465.
3. Wood KJ. The induction of tolerance to alloantigens using MHC class I molecules. Curr Opin Immunol. 5:1993;759-762.
4. Charlton B, Auchincloss HJ, Fathman CG. Mechanisms of transplantation tolerance. Annu Rev Immunol. 12:1994;207-234.
5. Mottram PL, Han WR, Purcell LJ, et al. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and IFN-γ in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation. 59:1995;559-565.
6. Hancock WW, Sayegh MH, Zheng XG, et al. Costimulatory function and expression of CD40-ligand. CD80 and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA. 93:1996;13967-13972.
7. Heidecke CD, Hancock WW, Wiegling A, et al. α/β-T receptor-directed therapy in rat allograft recipients: longterm survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of TH2-type cytokines. Transplantation. 61:1996;948-956.
8. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med. 181:1995;1869-1874.
9. Bach FH, Winkler H, Ferran C, et al. Endothelial activation is a barrier to xenotransplantation. Nature Med. 1:1995;869-873.
10. Cotran RS, Pober JS. Endothelial activation and inflammation. Prog Immunol. 8:1989;747-758.
11. Gerritsen ME, Bloor CM. Endothelial cell gene expression in response to injury. FASEB J. 7:1993;523-532.
12. Read MA, Whitley MZ, Williams A, et al. NK-κB and IκBa - an inducible regulatory system in endothelial activation. J Exp Med. 179:1994;503-512.
13. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Ann Rev Immunol. 12:1994;141-179.
14. White E. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1996;1-15.
15. Hockenbery DM, Oltvai ZN, Yin XM, et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
16. Boise L, Gonzalez G, Postema C, et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1993;597-608.
17. Chao DT, Linette GP, Boise LH, et al. Bcl-xL and Bcl-2 repress a common pathway of cell death. J Exp Med. 182:1995;821-828.
18. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Eng J Med. 330:1994;1431-1438.
19. Robaye B, Mosselmans R, Fiers W, et al. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol. 138:1991;447-453.
20. Buttke T, Sandstrom P. Oxidative stress as a mediator of apoptosis. Immunol Today. 15:1994;7-10.
21. Opipari AWJ, Boguski MS, Dixit VM. The A20 cDNA induced by tumor necrosis factor a encodes a novel type of zinc finger protein. J Biol Chem. 265:1990;14705-14708.
22. Karsan A, Yee E, Kaushansky K, et al. Cloning of a human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood. 87:1996;3089-3096.
23. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms and clinical application. FASEB J. 2:1988;2557-2568.
24. Abraham NG, Drummond GS, Lutton JD, et al. The biological significant and physiological role of heme oxygenase. Cell Physiol Biochem. 6:1996;129-168.
25. Kurata SI, Matsumoto M, Tsuji Y, et al. Lipopolysaccharide activates transcription of the heme oxygenase gene in mouse M1 cells through oxidative activation of NF-kB. Eur J Biochem. 239:1996;566-571.
26. Bach FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today. 18:1997;483-486.
27. Hancock WW, Buelow R. Prevention of chronic cardiac allograft rejection and transplant arteriosclerosis by induction of the protective gene, hemoxygenase. Transplant Proc. 1997;. (in press).
28. Hancock WW, Li X. Contribution of humoral responses to transplant arteriosclerosis and beneficial effects of IL-4-induced protective genes. Transplant Proc. 1997;. (in press).
29. Shi C, Lee WS, He Q, et al. Immunologic basis of transplant-associated arteriosclerosis. Proc Natl. Acad Sci USA. 93:1996;4051-4056.
30. Russell PS, Chase CM, Winn HJ, et al. Coronary atherosclerosis in transplanted mouse hearts: II. Importance of humoral immunity. J. Immunol. 152:1994;5135-5141.
31. Bach FH, Ferran C, Hechenleitner P, et al. Accommodation of vascularized xenografts: expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. Nature Med. 3:1997;196-204.
32. Cooper JT, Stroka DM, Brostjan C, et al. A 20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem. 271:1996;18068-18073.
33. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline responsive promoters. Proc Natl Acad Sci USA. 89:1992;5547-5551.
34. Wilson JM. A pharmacologic rheostat for gene therapy. Nature Med. 2:1996;977-978.
35. Tullius S., Hancock WW, Heeman U, et al. Reversibility of chronic renal allograft rejection: critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury. Transplantation. 58:1994;93-99.